Latest Insider Transactions at Silverback Therapeutics, Inc. (SBTX)
This section provides a real-time view of insider transactions for Silverback Therapeutics, Inc. (SBTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Silverback Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Silverback Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 13
2024
|
Pratik Shah |
SELL
Bona fide gift
|
Indirect |
1,332,900
-57.5%
|
-
|
Jun 12
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
95,862
-2.88%
|
$862,758
$9.15 P/Share
|
Jun 12
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
95,862
-2.88%
|
$862,758
$9.15 P/Share
|
Jun 11
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
4,138
-0.12%
|
$37,242
$9.0 P/Share
|
Jun 11
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
4,138
-0.12%
|
$37,242
$9.0 P/Share
|
Jun 07
2024
|
Pratik Shah |
SELL
Bona fide gift
|
Indirect |
1,332,950
-21.65%
|
-
|
Jun 04
2024
|
Pratik Shah |
BUY
Bona fide gift
|
Indirect |
1,332,900
+50.0%
|
-
|
Jun 04
2024
|
Pratik Shah |
SELL
Bona fide gift
|
Indirect |
1,332,900
-17.79%
|
-
|
Jun 04
2024
|
Pratik Shah |
SELL
Other acquisition or disposition
|
Indirect |
2,665,800
-26.25%
|
-
|
May 16
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
89,096
-2.6%
|
$801,864
$9.06 P/Share
|
May 16
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
89,096
-2.6%
|
$801,864
$9.06 P/Share
|
May 15
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
5,147
-0.15%
|
$46,323
$9.05 P/Share
|
May 15
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
5,147
-0.15%
|
$46,323
$9.05 P/Share
|
May 14
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
5,757
-0.17%
|
$51,813
$9.01 P/Share
|
May 14
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
5,757
-0.17%
|
$51,813
$9.01 P/Share
|
May 07
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-2.87%
|
$900,000
$9.34 P/Share
|
May 07
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
100,000
-2.87%
|
$900,000
$9.34 P/Share
|
Apr 23
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
130,993
+1.9%
|
$130,993
$1.14 P/Share
|
Apr 23
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
130,993
+1.9%
|
$130,993
$1.14 P/Share
|
Apr 19
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
188,491
+2.16%
|
$188,491
$1.14 P/Share
|
Apr 19
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Indirect |
188,491
+2.16%
|
$188,491
$1.14 P/Share
|
Apr 16
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-2.79%
|
$900,000
$9.28 P/Share
|
Apr 16
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
100,000
-2.79%
|
$900,000
$9.28 P/Share
|
Apr 09
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
100,000
-2.76%
|
$900,000
$9.28 P/Share
|
Apr 09
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-2.76%
|
$900,000
$9.28 P/Share
|
Mar 27
2024
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
505,954
+4.84%
|
$4,553,586
$9.79 P/Share
|
Mar 26
2024
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
457,745
+4.62%
|
$4,119,705
$9.55 P/Share
|
Mar 25
2024
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
437,600
+4.64%
|
$3,938,400
$9.06 P/Share
|
Mar 25
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
95,267
-2.56%
|
$857,403
$9.12 P/Share
|
Mar 25
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
95,267
-2.56%
|
$857,403
$9.12 P/Share
|
Mar 22
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
2,343
-0.06%
|
$21,087
$9.02 P/Share
|
Mar 22
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
2,343
-0.06%
|
$21,087
$9.02 P/Share
|
Mar 21
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
472
-0.01%
|
$4,248
$9.0 P/Share
|
Mar 21
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
472
-0.01%
|
$4,248
$9.0 P/Share
|
Mar 19
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
1,918
-0.05%
|
$17,262
$9.04 P/Share
|
Mar 19
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
1,918
-0.05%
|
$17,262
$9.04 P/Share
|
Mar 15
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
96,756
-2.57%
|
$870,804
$9.14 P/Share
|
Mar 15
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
96,756
-2.57%
|
$870,804
$9.14 P/Share
|
Mar 14
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
444
-0.01%
|
$3,996
$9.0 P/Share
|
Mar 14
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
444
-0.01%
|
$3,996
$9.0 P/Share
|
Mar 13
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
2,800
-0.07%
|
$25,200
$9.0 P/Share
|
Mar 13
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
2,800
-0.07%
|
$25,200
$9.0 P/Share
|
Feb 29
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
3,782
-0.07%
|
$34,038
$9.02 P/Share
|
Feb 29
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
3,782
-0.07%
|
$34,038
$9.02 P/Share
|
Feb 28
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
98,778
-1.71%
|
$889,002
$9.02 P/Share
|
Feb 28
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
98,778
-1.71%
|
$889,002
$9.02 P/Share
|
Feb 26
2024
|
Sarina Tanimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Indirect |
700
-0.01%
|
$6,300
$9.01 P/Share
|
Feb 26
2024
|
Richard E Lowenthal PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
700
-0.01%
|
$6,300
$9.01 P/Share
|
Sep 29
2023
|
Alexander A Fitzpatrick Chief Legal Officer |
BUY
Open market or private purchase
|
Direct |
46,258
+34.14%
|
$138,774
$3.78 P/Share
|
Sep 28
2023
|
Alexander A Fitzpatrick Chief Legal Officer |
BUY
Open market or private purchase
|
Direct |
40,000
+48.21%
|
$120,000
$3.62 P/Share
|